HSBC/CALL/FIELMANN/40/0.1/18.12.24 Share Price

Warrant

DE000HG63R59

Market Closed - BOERSE MUENCHEN 01:07:12 05/07/2024 am IST
0.4 EUR -2.44% Intraday chart for HSBC/CALL/FIELMANN/40/0.1/18.12.24
Current month-11.11%
1 month-25.93%
Date Price Change
04/24/04 0.4 -2.44%
03/24/03 0.41 -2.38%
02/24/02 0.42 -19.23%
01/24/01 0.52 +15.56%
28/24/28 0.45 -6.25%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 01:07 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying FIELMANN GROUP AG
Issuer HSBC
WKN HG63R5
ISINDE000HG63R59
Date issued 24/11/2022
Strike 40
Maturity 18/12/2024 (167 Days)
Parity 10 : 1
Emission price 0.66
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 1.4
Lowest since issue 0.31
Delta0.64x
Omega 6.725
Premium3.89x
Gearing10.47x
Moneyness 1.060
Difference Strike -2.4
Difference Strike %-6.00%
Spread 0.03
Spread %7.14%
Theoretical value 0.4050
Implied Volatility 26.21 %
Total Loss Probability 42.14 %
Intrinsic value 0.2400
Present value 0.1650
Break even 44.05 €
Theta-0x
Vega0.01x
Rho0.01x

Company Profile

Fielmann Group AG, formerly known as, Fielmann AG is a Germany-based manufacturer of glasses, contact lenses and related eyewear products. The Company's optical product range includes frames, lenses, sunglasses, contact lenses, safety eyewear, related articles, accessories and all kinds of merchandise including bifocal and varifocal optical glasses. The Company operates through numerous subsidiaries and retailers located in Germany, Switzerland, Luxembourg, the Netherlands and Poland, among others. The production is conducted by Rathenower Optik GmbH. The Company is subsidiary of Korva SE, which is part of Inter-Optik GmbH & Co KG.
Sector
-
More about the company

Ratings for Fielmann Group AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Fielmann Group AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
42.4 EUR
Average target price
55.57 EUR
Spread / Average Target
+31.06%
Consensus